Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
04/2003
04/10/2003WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof
04/10/2003WO2003029185A1 Novel compounds
04/10/2003WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003028728A1 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands
04/10/2003WO2003028459A1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides
04/10/2003WO2003028458A1 N-thio-nicotinamide derivatives and related compounds for use as pesticides
04/10/2003WO2003002974A3 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
04/10/2003WO2002089738A3 Proteomimetic compounds and methods
04/10/2003WO2002078596A3 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye
04/10/2003WO2002050035A3 Insecticidal and fungicidal (2,6-dichloro-4-pyridyl) methylcarbamates used as plant protective agents
04/10/2003WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
04/10/2003US20030070188 Vanillin biosynthetic pathway enzyme from Vanilla planifolia
04/10/2003US20030069289 Alzheimer*s disease
04/10/2003US20030069284 Anticancer agent
04/10/2003US20030069272 Prevent joint stiffness; adjust concentration of synovial fluid
04/10/2003US20030069267 Modulators of protein tyrosine phosphatases (PTPases)
04/10/2003US20030069250 Anticoagulants
04/10/2003US20030069242 3-arylphenyl sulfide derivative and insecticide and miticide
04/10/2003US20030069225 Synthesis of taxol enhancers
04/10/2003US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses.
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003US20030068528 Organic light emitting devices having carrier blocking layers comprising metal complexes
04/10/2003US20030066988 Electroconductivity coloring
04/10/2003CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases
04/09/2003EP1300464A1 Fungal cell wall synthesis gene
04/09/2003EP1300402A1 Alkoxybenzylamines with antimicrobial properties
04/09/2003EP1300396A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
04/09/2003EP1299359A1 Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole
04/09/2003EP1299358A2 Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
04/09/2003EP1299354A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
04/09/2003EP1299123A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
04/09/2003EP1021457B1 Method for the site specific synthesis of novel 3-hydroxypyridin-4(1h)-ones derivatives from aminoitols, products obtained by this method and their applications
04/09/2003EP0946165B1 Integrin antagonists
04/09/2003EP0918746B1 Immunotherapeutic agents and their use in the reduction of cytokine levels
04/09/2003EP0873123B1 Inhibitors of protein isoprenyl transferases
04/09/2003EP0843663B1 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases
04/09/2003EP0771197B1 Use of heterocyclic compounds as dopamines-d 3- ligands
04/09/2003EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties
04/09/2003EP0674623B1 Bicyclic fibrinogen antagonists
04/09/2003CN1409705A Pyridine derivatives having fungicidal activity and process to produce and use same
04/09/2003CN1409704A Heterocycle derivatives and drugs
04/09/2003CN1409700A Process for preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties
04/09/2003CN1408708A Process for synthesizing 2-pyridine chromium formate of fodder additive
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/09/2003CN1105106C Naphthol derivatives and rpocess for preparation thereof
04/09/2003CN1105105C Process for preparation of 2-(pyrid-2-yloxymethyl) phenylacetates compounds as pesticide intermediate
04/09/2003CN1104947C Preparation of alumen antimonate catalyst by using tin dioxide hydrate
04/09/2003CN1104924C Thermally-managed separation and dewatering processes for recovering acid products
04/08/2003US6545160 αaminocetic acid derivatives- α4β7 receptor antagonists
04/08/2003US6545159 Vinyl-phenyl pyridine monomers and polymers prepared therefrom
04/08/2003US6545152 Viricides; polymerase enzyme inhibitor
04/08/2003US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa
04/08/2003US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof
04/08/2003US6545029 Antiosteoporotic, antirestenotic, anticarcinogenic and antiatherosclerotic
04/08/2003US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation
04/08/2003US6544986 Such as 5-(N,N-dibenzyl)aminocarbonyl-2-pyridone; enzyme inhibitors; for treatment of Alzheimer's disease
04/08/2003US6544974 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity
04/08/2003US6544499 Polysiloxane or silicone resin, a linker, and a molecular hook for treating amino acid based substrates; hair care
04/08/2003US6544298 Dyeing human hair using coupler
04/08/2003CA2123548C Piperazine derivatives
04/08/2003CA2103829C Peg-interferon conjugates
04/08/2003CA2101423C Benzamides
04/08/2003CA2033190C N-phenylalkyl substituted alpha-amino carboxamide derivatives and process for their preparation
04/04/2003WO2002030896A1 2,2-diphenylbutanamide derivatives and medicines containing the same
04/04/2003CA2424979A1 2,2-diphenylbutanamide derivatives and medicines containing the same
04/03/2003WO2003027116A2 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
04/03/2003WO2003027061A2 Muscarinic agonists
04/03/2003WO2003027059A1 Acid amide derivatives, process for producing these, and pest control agent containing these
04/03/2003WO2003026415A2 Insecticidal diamides
04/03/2003WO2002102766A3 Combretastatin a-3 prodrug
04/03/2003US20030065208 Triphenylphosphine derivative, production process therefor, palladium complex thereof, and process for producing biaryl derivative
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003US20030065176 Anticoagulant; cardiovascular disorders
04/03/2003US20030065034 Antiinflammatory agents; coupling sulfonyl halide with aromatic amine compound
04/03/2003US20030065014 Substance for inducing apoptosis
04/03/2003US20030065013 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
04/03/2003US20030065011 Antiinflammatory agents, anticancer agents, antipyretics; side effect reduction
04/03/2003US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
04/03/2003US20030064983 Headaches; antiarthritic agents; respiratory system disorders; psychological disorders
04/03/2003US20030064977 Viricides
04/03/2003US20030064976 Reacting ammonium formate, aldehyde and alkyl isocyanate
04/03/2003US20030064173 Having electrically switchable transparency essentially independent of the polarization of incident light
04/03/2003US20030064102 Antimicrobial Composition
04/03/2003US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
04/03/2003US20030061667 Bis(2,4-diaminophenoxy)pyridines and pyrimidines
04/02/2003EP1298116A1 Process for preparing alkanesulfonyl pyridines
04/02/2003EP1298115A1 Process for the preparation of polyhydric alcohols
04/02/2003EP1297834A1 Inhibitor for enzyme having two divalent metal ions as active centers
04/02/2003EP1296983A1 Novel process for the preparation of pyrazolopyrimidinones
04/02/2003EP1296971A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
04/02/2003EP1296952A1 Benzoylpyridine derivative or its salt, fungicide containing it as an active ingredient, its production process and intermediate for producing it
04/02/2003EP1296951A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis
04/02/2003EP1296945A1 Sulfonamide derivatives
04/02/2003EP1296942A1 Glucagon antagonists/inverse agonists
04/02/2003EP1296940A1 Amidine derivatives as selective antagonists of nmda receptors
04/02/2003EP1296938A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
04/02/2003EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones